sulfapyridine has been researched along with Carcinoma, Hepatocellular in 1 studies
Sulfapyridine: Antibacterial, potentially toxic, used to treat certain skin diseases.
sulfapyridine : A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Hazek, RMM | 1 |
| Zaher, NH | 1 |
| El-Gazzar, MGM | 1 |
| Fadel, NA | 1 |
| El-Sabbagh, WA | 1 |
1 other study available for sulfapyridine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Novel VEGFR2 inhibitors with thiazoloquinoxaline scaffold targeting hepatocellular carcinoma with lower cardiotoxic impact.
Topics: Animals; Carcinoma, Hepatocellular; Cardiotoxicity; Drug-Related Side Effects and Adverse Reactions; | 2023 |